Gantalao, Romio T.
HRN: 26-95-25 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/13/2025
04/20/2025
IV
2.25g
Q6
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes